Elucida Oncology to Present Preclinical Data on ELU001 at the Antibody Engineering & Therapeutic Conference

NEXT STORY
Verrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for VP-102 for the Treatment of Molluscum Contagiosum
PREV STORY
AIDSVu Releases 2019 Data and Interactive Maps Showing State of HIV Across the U.S.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Fluidigm Launches Imaging Mass Cytometry Immuno-Oncology Panel Kits and Advanced CyTOF Software at the 2019 World Molecular Imaging Congress (WMIC)

author_avatar
NASDAQ Market News

Aclaris Therapeutics Reports Second Quarter 2020 Financial Results and Provides R&D and Business Highlights

author_avatar
NASDAQ Market News

Beroni Group Expands Into Strategic Relationship With Jinshui Science & Education Park In Zhengzhou, China

author_avatar
NASDAQ Market News